← Eichor
Study identifier: NCT06819670 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Study to Prevent Infantile Spasms Relapse

Condition: Infantile Spasms · Infantile Epileptic Spasms Syndrome · West Syndrome  ·  Sponsor: University of California, Los Angeles

PhasePhase 2
Planned participants40
Who can joinAll sexes, 2 Months to 18 Months
Healthy volunteersNo

About this study

After initially successful treatment, many children with infantile spasms unfortunately have a relapse, and relapse is linked to poor long-term outcomes such as autism and other forms of epilepsy. The aim of this study is to determine if treatment with low-dose prednisolone is safe, well tolerated, and effective in reducing the risk of relapse.

This description comes directly from the study's public registry record.

Talk to the study team

Shaun A. Hussain, MD, MS  ·  310-206-7630  ·  shussain@mednet.ucla.edu

Angela L. Martinez  ·  310-206-7630  ·  angelamartinez@mednet.ucla.edu

Always discuss trial participation with your own doctor first.

Locations (1)

UCLALos Angeles, California, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06819670